Picture of International Biotechnology Trust logo

IBT International Biotechnology Trust News Story

0.000.00%
gb flag iconLast trade - 00:00
FinancialsBalancedSmall Cap

RCS - Intnl. Biotechnology - Investor Presentation via Investor Meet Company

RNS Number : 2771D

Intl. Biotechnology Trust PLC

06 May 2026

 

INTERNATIONAL BIOTECHNOLOGY TRUST PLC ("IBT")

 

Investor Presentation via Investor Meet Company

 

International Biotechnology Trust plc is pleased to announce that Ailsa Craig and Marek Poszepczynski will provide a live presentation on the Company's results for the six months ended 28 February 2026 via the Investor Meet Company platform on Tuesday 12 May 2026 at 09:00 am BST.

 

The presentation is open to all existing and potential investors. Questions can be submitted pre-event via your Investor Meet Company dashboard before the meeting or at any time during the live presentation.

 

Investors can sign up to Investor Meet Company for free and add to meet INTERNATIONAL BIOTECHNOLOGY TRUST PLC via:

https://www.investormeetcompany.com/international-biotechnology-trust-plc/register-investor

 

Investors who already follow INTERNATIONAL BIOTECHNOLOGY TRUST PLC on the Investor Meet Company platform will automatically be invited.

 

ENDS

 

Enquiries:

 

Schroder Investment Management Limited
Charlotte Banks (Press)
Kirsty Preston
Natalia de Sousa/ Michelle Taiwo (Company Secretary)
020 7658 6000
020 7658 6000
Kaso Legg Communications (Financial PR)
Charles Gorman
Henry Taylor
Effie Aye Maung Hider
IBT@kl-communications.com
    This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com. RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.   END     NRAZZGGKZVGGVZM

Recent news on International Biotechnology Trust

See all news